- Product NameOritavancin diphosphate
- Brief DescriptionInhibitors
- Purification99.49%
- Biological ActivityOritavancin diphosphate is a novel semisynthetic glycopeptide antibiotic being developed for the treatment of serious Gram-positive bacterial infections.
- Target NameOthers
- CAS No. 192564-14-0
- Calculated MW 1989.09
- Formulation C86H103Cl3N10O34P2
- Storage 3 years -20˚C powder;2 years -80˚C in solvent;